Integer (NYSE:ITGR) Rating Lowered to “Strong Sell” at Zacks Research

Integer (NYSE:ITGR) was downgraded by research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a report released on Monday,Zacks.com reports.

ITGR has been the topic of a number of other research reports. Raymond James Financial reiterated an “outperform” rating and issued a $101.00 price target on shares of Integer in a report on Monday, February 23rd. Wells Fargo & Company lifted their target price on shares of Integer from $72.00 to $84.00 and gave the company an “equal weight” rating in a report on Friday, February 20th. Citigroup reduced their target price on shares of Integer from $92.00 to $89.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Wall Street Zen lowered shares of Integer from a “buy” rating to a “hold” rating in a report on Sunday, January 25th. Finally, Weiss Ratings upgraded shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, February 24th. Four equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Integer currently has a consensus rating of “Hold” and an average target price of $98.29.

Integer Trading Up 0.3%

Shares of ITGR opened at $85.15 on Monday. The company has a debt-to-equity ratio of 0.77, a current ratio of 3.75 and a quick ratio of 2.38. The firm has a 50 day simple moving average of $86.07 and a 200-day simple moving average of $80.63. Integer has a 1-year low of $62.00 and a 1-year high of $123.78. The stock has a market cap of $2.89 billion, a price-to-earnings ratio of 21.23, a price-to-earnings-growth ratio of 1.47 and a beta of 0.67.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.01). Integer had a return on equity of 12.83% and a net margin of 7.64%.The business had revenue of $439.58 million for the quarter, compared to analysts’ expectations of $426.48 million. During the same period last year, the business earned $1.31 earnings per share. The company’s revenue for the quarter was up .5% on a year-over-year basis. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. Equities analysts forecast that Integer will post 6.11 EPS for the current fiscal year.

Insider Buying and Selling at Integer

In related news, VP Tommy P. Thomas sold 825 shares of Integer stock in a transaction on Friday, March 13th. The shares were sold at an average price of $85.00, for a total transaction of $70,125.00. Following the sale, the vice president owned 4,381 shares of the company’s stock, valued at $372,385. The trade was a 15.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 1.10% of the company’s stock.

Institutional Investors Weigh In On Integer

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ITGR. Tudor Investment Corp ET AL increased its stake in Integer by 50,787.5% during the 3rd quarter. Tudor Investment Corp ET AL now owns 29,500,000 shares of the medical equipment provider’s stock worth $28,606,000 after buying an additional 29,442,029 shares during the period. Irenic Capital Management LP purchased a new stake in Integer during the 4th quarter worth $99,109,000. Alliancebernstein L.P. increased its stake in Integer by 885.1% during the 2nd quarter. Alliancebernstein L.P. now owns 1,106,091 shares of the medical equipment provider’s stock worth $136,016,000 after buying an additional 993,810 shares during the period. Millennium Management LLC increased its stake in Integer by 3,350.2% during the 4th quarter. Millennium Management LLC now owns 677,108 shares of the medical equipment provider’s stock worth $53,106,000 after buying an additional 657,483 shares during the period. Finally, J. Goldman & Co LP purchased a new stake in Integer during the 4th quarter worth $40,531,000. Hedge funds and other institutional investors own 99.29% of the company’s stock.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.